Your browser doesn't support javascript.
loading
Clinical course of SARS-CoV-2 infection and recovery in lung transplant recipients.
Trindade, Anil J; Chapin, Kaitlyn C; Gannon, Whitney D; Hoy, Haley; Demarest, Caitlin T; Lambright, Eric S; McPherson, Katie A; Norfolk, Stephanie G; Robbins, Ivan M; Bacchetta, Matthew; Erasmus, David B; Shaver, Ciara M.
Affiliation
  • Trindade AJ; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Chapin KC; Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Gannon WD; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Hoy H; Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Demarest CT; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Lambright ES; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • McPherson KA; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Norfolk SG; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Robbins IM; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Bacchetta M; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Erasmus DB; Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Shaver CM; Department of Biomedical Engineering, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Transpl Infect Dis ; 24(6): e13967, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36271645
BACKGROUND: Reports on outcomes following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in lung transplant recipients remain limited. METHODS: We performed a single-center, observational study of outcomes in lung transplant recipients diagnosed with SARS-CoV-2 between 5/1/2020 and 3/15/2022 that were followed for a median of 123 days. We analyzed changes in spirometry, acute lung allograft dysfunction (ALAD) incidence, hospitalization, mechanical ventilation needs, secondary infection, and survival. RESULTS: In our cohort of 336 patients, 103 developed coronavirus disease (COVID) (27 pre-Delta, 20 Delta, and 56 Omicron-era). Twenty-five patients (24%) required hospitalization and 10 patients ultimately died (10%). Among 85 survivors who completed ambulatory spirometry, COVID-19 did not alter change in forced expiratory volume in 1 s (FEV1 ) or forced vital capacity (FVC) over time compared to the preceding 6 months. The pre-COVID FEV1 change was -0.05 ml/day (IQR -0.50 to 0.60) compared to -0.20 ml/day (IQR -1.40 to 0.70) post-COVID (p = .16). The pre-COVID change in FVC was 0.20 ml/day (IQR -0.60 to 0.70) compared to 0.05 ml/day (IQR -1.00 to 1.10) post-COVID (p = .76). Although the cohort overall had stable lung function, 33 patients (39%) developed ALAD or accelerated chronic lung allograft dysfunction (FEV1 decline >10% from pre-COVID baseline). Nine patients (35%) with ALAD recovered lung function. Within 3 months of acute COVID infection, 18 patients (17%) developed secondary infections, the majority being bacterial pneumonia. Finally, vaccination with at least two doses of mRNA vaccine was not associated with improved outcomes. CONCLUSIONS: This study describes the natural history of SARS-CoV-2 infection in a large cohort of lung transplant recipients. Although one third of patients develop ALAD requiring augmented immunosuppression, infection with SARS-CoV-2 is not associated with worsening lung function.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Observational_studies Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Observational_studies Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2022 Document type: Article Affiliation country: Country of publication: